ASB-11, or Ankyrin repeat and SOCS box-containing protein 11, is part of the ASB family of proteins. The members of this family are characterized by the presence of multiple ankyrin repeat domains and a SOCS (Suppressor of Cytokine Signaling) box. The ankyrin repeats are known for their protein-protein interaction capabilities, allowing these proteins to interact with various other proteins within the cell. On the other hand, the SOCS box is crucial for the recruitment of ubiquitin-conjugating enzymes, positioning ASB proteins as potential E3 ubiquitin ligases that can target specific proteins for ubiquitination and subsequent proteasomal degradation.
Inhibitors of ASB-11 would be molecules devised to modulate the function, expression, or stability of the ASB-11 protein. Given ASB-11's potential role in protein ubiquitination and degradation, its inhibition could influence the stability and function of its target proteins within the cell. Potential ASB-11 inhibitors might comprise small molecules that bind directly to the protein, hindering its interaction with ubiquitin-conjugating enzymes or its substrate proteins. By blocking these interactions, the ubiquitination and degradation of target proteins could be altered, potentially impacting various cellular processes. Another approach might involve molecules that interfere with the proper folding or post-translational modifications of ASB-11, which can impact its activity or interactions with other cellular components. Moreover, advanced molecular tools, such as RNA interference or antisense oligonucleotides, might be employed to regulate ASB-11 expression at the genetic level. Delving into the effects of ASB-11 inhibition can offer a more profound understanding of its specific roles in protein homeostasis and the broader implications of modulating protein ubiquitination and degradation pathways in cellular function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor and can prevent the degradation of ubiquitinated proteins, potentially influencing ASB-11's role in protein degradation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, another proteasome inhibitor, can influence the ubiquitin-proteasome pathway, potentially affecting ASB-11's function. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Nutlin-3 stabilizes p53 by inhibiting its degradation, which might influence proteins associated with ubiquitination processes like ASB-11. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
As a proteasome inhibitor, lactacystin can interfere with protein degradation, potentially affecting ASB-11 function. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Epoxomicin selectively inhibits the proteasome, potentially impacting the ubiquitin-proteasome pathway and ASB-11's function. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
MLN4924 inhibits NEDD8-activating enzyme, affecting protein degradation and potentially influencing ASB-11 activity. | ||||||
MLN7243 | 1450833-55-2 | sc-507338 | 5 mg | $340.00 | ||
TAK-243 is a ubiquitin-activating enzyme inhibitor, potentially influencing the ubiquitin-proteasome system and ASB-11's role. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
As a ubiquitin-activating enzyme inhibitor, Pyr-41 can interfere with ubiquitin transfer, potentially affecting ASB-11's function. | ||||||
JNJ 26854165 | 881202-45-5 | sc-364514 sc-364514A | 5 mg 25 mg | $171.00 $577.00 | ||
A proteasome inhibitor that might influence ubiquitin-mediated protein degradation and ASB-11's role. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
Carfilzomib is another proteasome inhibitor that can interfere with protein degradation, potentially influencing ASB-11 activity. | ||||||